SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 13G

 

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN THE STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

(Amendment No. 3)*

North American Scientific, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

65715D209

(CUSIP Number)

 

January 18, 2008

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


 

SCHEDULE 13G

 

CUSIP NO. 65715D209

2 of 6

 

1

 

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP         

(a) x
(b) o

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF

 

SHARES

 

BENEFICIALLY

 

OWNED BY EACH

 

REPORTING

 

PERSON WITH

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

13,365,234 shares of Common Stock (See Item 4)

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

13,365,234 shares of Common Stock (See Item 4)

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

13,365,234 shares of Common Stock (See Item 4)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                  

x

1

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

14.4% (See Item 4)

12

TYPE OF REPORTING PERSON

 

IN

 

 


 

SCHEDULE 13G

 

CUSIP NO. 65715D209

3 of 6

 

 

Item 1(a).

Name of Issuer:

North American Scientific, Inc. (the “Issuer”).

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

20200 Sunburst Street

Chatsworth, CA 91311

 

Items 2(a),

(b) and (c).

Name of Persons Filing , Address of Principal Business Office and Citizenship:

This Amendment No. 3 to Schedule 13G is being filed on behalf of Michael A. Roth and Brian J. Stark, as joint filers (collectively, the “Reporting Persons”).

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Amendment No. 3 to Schedule 13G as Exhibit 1, pursuant to which the Reporting Persons have agreed to file this Amendment No. 3 to Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The principal business office of the Reporting Persons is 3600 South Lake Drive, St. Francis, WI 53235. The Reporting Persons are citizens of the United States of America.

Item 2(d).

Title of Class of Securities:

Common Stock, par value $0.01 per share (the “Common Stock”)

 

Item 2(e).

CUSIP Number:

65715D209

Item 3.

Not applicable.

Item 4.

Ownership.

(a)

Amount beneficially owned :

13,365,234 shares of Common Stock (See Item 4)

(b)

Percent of class :

Based on 92,609,492 shares of Common Stock outstanding as indicated on Issuer’s Schedule 14A filed on December 31, 2007 and 508,130 shares of Common Stock issuable upon the exercise of warrants held by the Reporting Persons, the Reporting Persons hold approximately 14.4%* of the issued and outstanding Common Stock of the Issuer.

 


 

SCHEDULE 13G

 

CUSIP NO. 65715D209

4 of 6


(c)

Number of shares to which such person has:

(i)

Sole power to vote or direct the vote: 0

(ii)

Shared power to vote or direct the vote: 13,365,234 shares of Common Stock*

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose of or direct the disposition of: 13,365,234 shares of Common Stock*

*The Reporting Persons beneficially own an aggregate of 13,365,234 shares of Common Stock. The foregoing amount of Common Stock and percentage ownership represent the combined indirect holdings of Michael A. Roth and Brian J. Stark. The shares of Common Stock reported in this Amendment No. 3. to Schedule 13G does not include 1,280,409 shares of Common Stock issuable upon the exercise of warrants held by the Reporting Persons. Such warrants held by the Reporting Persons are subject to conversion caps that preclude the holder thereof from utilizing its exercise rights to the extent that it would beneficially own (determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) in excess of 4.99% and 9.99% of the Common Stock, giving effect to such exercise.

All of the foregoing represents an aggregate of 13,365,234 shares of Common Stock held directly by SF Capital Partners Ltd. (“SF Capital”). The Reporting Persons direct the management of Stark Offshore Management LLC (“Stark Offshore”), which acts as the investment manager and has sole power to direct the management of SF Capital. As the Managing Members of Stark Offshore, the Reporting Persons possess voting and dispositive power over all of the foregoing shares. Therefore, for the purposes of Rule 13d-3 under the Exchange Act, the Reporting Persons may be deemed to be the beneficial owners of, but hereby disclaim such beneficial ownership of, the foregoing shares.

Item 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported By the Parent Holding Company.

Not applicable

 


 

SCHEDULE 13G

 

CUSIP NO. 65715D209

5 of 6

 

 

Item 8.

Identification and Classification of Members of the Group.

Not applicable

Item 9.

Notice of Dissolution of a Group.

Not applicable

Item 10.

Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 


 

SCHEDULE 13G

 

CUSIP NO. 65715D209

6 of 6

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:

February 17, 2009

 

/s/ Michael A. Roth                                              

Michael A. Roth

/s/ Brian J. Stark                                                       

Brian J. Stark

 


North American Scientific (MM) (NASDAQ:NASM)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 North American Scientific (MM) 차트를 더 보려면 여기를 클릭.
North American Scientific (MM) (NASDAQ:NASM)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 North American Scientific (MM) 차트를 더 보려면 여기를 클릭.